Immunodeficiency 89 (IKZF3 Deficiency): A Patient Guide

Immunodeficiency 89, also known as IKZF3 deficiency or AIOLOS deficiency, is an exceptionally rare genetic condition that affects the foundation of the immune system. At its core, the condition is caused by a change in the IKZF3 gene, which is responsible for producing a protein called AIOLOS ^[1]. In a healthy body, AIOLOS acts as a vital “control switch” that tells white blood cells how to grow, mature, and eventually fight off germs ^[2]. Because this mutation is autosomal dominant, a single altered copy of the gene is enough to disrupt this process, often by creating a “broken” protein that prevents the healthy version from doing its job ^[3][1].

This condition is classified as a combined immunodeficiency, meaning it weakens both the B cells, which produce protective antibodies, and the T cells, which coordinate the body’s entire immune response ^[1]. This dual defect leaves the body vulnerable to a wide range of threats. Children with this diagnosis may experience frequent, stubborn infections of the ears and lungs, as well as “opportunistic” infections like Pneumocystis jirovecii pneumonia (PJP)—a type of fungal lung infection that usually only affects people with significant T-cell issues ^[1][3]. Beyond infections, some children may struggle with chronic diarrhea or a difficulty gaining weight, often referred to as failure to thrive or poor weight gain ^[3].

Because the body cannot reliably protect itself, the standard of care focuses on building a “safety net” around the immune system. This often includes Immunoglobulin Replacement Therapy (IgRT), which provides the body with the antibodies it cannot make on its own, and daily or weekly preventative (prophylactic) medications to stop dangerous germs from taking hold ^[4][5]. It is important to understand that while IgRT helps prevent bacterial infections, it does not repair the T-cell defect or guarantee protection from opportunistic infections like PJP. While these treatments help manage the day-to-day risks, doctors also maintain a long-term watch for signs of immune dysregulation—a state where the immune system becomes “confused” and may cause organ enlargement or, as seen in a limited number of adult relatives, potential long-term risks like blood-related cancers ^[2][1].

Living with such a rare diagnosis means your family is part of a very small global community of patients and researchers. Because the condition was only first identified in 2021, the medical understanding of IKZF3 deficiency is growing every year ^[1]. Your child’s medical team will use the most current general guidelines for immune disorders to tailor a plan that fits your child’s specific needs ^[4]. While the road ahead requires careful monitoring and many protective measures, these steps are designed to allow your child to grow, learn, and live as fully as possible while the science continues to advance.